TherapeuticsMD (TXMD) Intangibles (2010 - 2026)

TherapeuticsMD has reported Intangibles for 17 years, with the latest figure at $6.2 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles rose 49.44% year-over-year to $6.2 million; the trailing twelve-month figure through Mar 2026 stood at $6.2 million (up 49.44% YoY), and the FY2025 full-year result was $6.2 million, down 3.06% from the prior year.
• Intangibles for Q1 2026 stood at $6.2 million, roughly flat from $6.2 million in the prior quarter.
• The five-year high for Intangibles was $48.4 million in Q3 2022, with the low at $3.9 million in Q3 2025.
• Historically, Intangibles has averaged $12.9 million across 5 years, with a median of $6.4 million in 2024.
• Annual changes were most pronounced in 2023 — Intangibles tumbled 86.26% — and 2026, when it surged 49.44%.
• TherapeuticsMD's Intangibles stood at $6.9 million in 2022, then retreated by 12.17% to $6.1 million in 2023, then rose by 4.61% to $6.4 million in 2024, then retreated by 3.06% to $6.2 million in 2025, then changed by 0.0% to $6.2 million in 2026.
• The last three Intangibles figures came in at $6.2 million (Q1 2026), $6.2 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.